Search
for
Sort by
Research 481–510 of 1000+
- Cell-free regenerative medicine: identifying the best source of mesenchymal stem cells for skin therapy in Systemic Sclerosis
- Acne Necrotica in a Woman With Systemic Lupus Erythematosus and Systemic Sclerosis
- Dermatology patient-derived health utility of facial angiofibroma associated with tuberous sclerosis complex
- Beyond Perceived Stress: Hair Cortisol is linked with Cognition and Fatigue in Black and White Patients with Multiple Sclerosis
- Health Utility of Facial Angiofibroma associated with Tuberous Sclerosis Complex
- Hair Cortisol as a Biomarker of Chronic Stress in Community-Dwelling Adults With Longstanding Multiple Sclerosis
- Alopecia Associated to the Use of Disease-Modifying Therapies for Multiple Sclerosis: A Scoping Review Protocol
- Ayurvedic management of systemic sclerosis - A case report
- AB1159 HIGH FAT DIET AND THE ADIPOCYTE TO MYOFIBROBLAST TRANSITION: IMPLICATIONS FOR SYSTEMIC SCLEROSIS CUTANEOUS FIBROSIS
- Skin Complications Associated with Interferon-β Treatment in Patients with Multiple Sclerosis, Tehran in 2021 - 2
- BH14 Multiple sclerosis and alopecia areata: drug-induced alopecia areata or coexisting autoimmune phenomena?
- Hair loss due to treatment of multiple sclerosis
- Severe Alopecia Complicating Systemic Sclerosis
- Abstract 2469: Increased cathepsin B expression in cultured tuberous sclerosis skin tumor cells and patient tumor tissues
- Transudation of phVEGF165 into sclerotic skin to promote hair growth and regeneration in mice
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice?
- Experimental Production of Cutaneous Calcinosis and Sclerosis with Dihydrotachysterol (AT-10) 1
- Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management
- Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
- Interfacial Adipose Tissue in Systemic Sclerosis
- Lanostane-type triterpenes from the sclerotium of Inonotus obliquus (Chaga mushrooms) as proproliferative agents on human follicle dermal papilla cells
- Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report
- Role of isoflavones in multiple sclerosis
- Exploring the Dermoscopic Patterns in Tuberous Sclerosis
- BH25 Alopecia in a patient undergoing multiple treatments for multiple sclerosis: a rare presentation and case review
- 3162 Alopecia universalis after alemtuzumab in multiple sclerosis - a nine year follow up and review of literature
- Capillaroscopic patterns in patients with systemic sclerosis, psoriasis and alopecia and their correlations with serum concentrations of several angiogenic markers
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis